Concepedia

Samuel J. Resnick

SJ

Statistics

Publications

5

Citations

201

H-Index

5

Active since

2018

Affiliations

Columbia University(Current)

Columbia University Irving Medical Center

Aaron Diamond AIDS Research Center

Samuel J. Resnick is an author at Columbia University specializing in drug discovery, antiviral structure-activity relationships, and molecular virology.

ORCID

Publications per year

2018–2025

5

Publications

5

Development of optimized drug-like small molecule inhibitors of the SARS-CoV-2 3CL protease for treatment of COVID-19

Hengrui Liu, Sho Iketani, Arie Zask et al. · Nature Communications · 2022 · 96 citations · Full text

, , +17

Inhibitors of Coronavirus 3CL Proteases Protect Cells from Protease-Mediated Cytotoxicity

Samuel J. Resnick, Sho Iketani, Seo Jung Hong et al. · Journal of Virology · 2021 · 49 citations · Full text

, , +15

Understanding health‐related quality of life in adult women with metastatic cancer who have dependent children

Eliza M. Park, Allison M. Deal, Justin M. Yopp et al. · Cancer · 2018 · 34 citations · Full text

, , +16

A simplified cell-based assay to identify coronavirus 3CL protease inhibitors

Samuel J. Resnick, Sho Iketani, Seo Jung Hong et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 11 citations · Full text

, , +13

Development of small molecule non-covalent coronavirus 3CL protease inhibitors from DNA-encoded chemical library screening

Hengrui Liu, Arie Zask, F. Forouhar et al. · Nature Communications · 2025 · 11 citations · Full text

, , +13

1–5 of 5